These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36882341)

  • 21. Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
    Ruiz Vargas E; Sposato LA; Lee SAW; Hachinski V; Cipriano LE
    Stroke; 2018 Dec; 49(12):2844-2850. PubMed ID: 30571418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
    J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.
    Baker WL; Cios DA; Sander SD; Coleman CI
    J Manag Care Pharm; 2009 Apr; 15(3):244-52. PubMed ID: 19326955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A consultant-led anticoagulation review of all patients in one clinical commissioning group to prevent atrial fibrillation related stroke.
    Grayson AD; Garnett F; Davies M; Connor N; Hughes C; Cooper JP
    Int J Clin Pract; 2020 Apr; 74(4):e13465. PubMed ID: 31854038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study).
    Yong C; Azarbal F; Abnousi F; Heidenreich PA; Schmitt S; Fan J; Than CT; Ullal AJ; Yang F; Phibbs CS; Frayne SM; Ho PM; Shore S; Mahaffey KW; Turakhia MP
    Am J Cardiol; 2016 Jan; 117(1):61-8. PubMed ID: 26552504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Examination of anticoagulation prescription among elderly patients with atrial fibrillation after in-hospital fall.
    Obi CA; Bulsara K; Izard S; Delicce A; Smith A; Kim EJ
    J Thromb Thrombolysis; 2022 Apr; 53(3):683-689. PubMed ID: 34480676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aortic Stenosis and Outcomes in Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Teppo K; Airaksinen KEJ; Biancari F; Jaakkola J; Halminen O; Linna M; Haukka J; Putaala J; Mustonen P; Kinnunen J; Luojus A; Hartikainen J; Aro AL; Lehto M
    J Am Heart Assoc; 2023 May; 12(9):e029337. PubMed ID: 37119067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation.
    Yong CM; Tremmel JA; Lansberg MG; Fan J; Askari M; Turakhia MP
    J Am Heart Assoc; 2020 May; 9(10):e015689. PubMed ID: 32394763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation.
    Shen AY; Yao JF; Brar SS; Jorgensen MB; Wang X; Chen W
    Stroke; 2008 Oct; 39(10):2736-43. PubMed ID: 18635860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciding on anticoagulating the oldest old with atrial fibrillation: insights from cost-effectiveness analysis.
    Desbiens NA
    J Am Geriatr Soc; 2002 May; 50(5):863-9. PubMed ID: 12028173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
    Dallalzadeh LO; Go AS; Chang Y; Borowsky LH; Fang MC; Singer DE
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27451456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US.
    Sullivan PW; Arant TW; Ellis SL; Ulrich H
    Pharmacoeconomics; 2006; 24(10):1021-33. PubMed ID: 17002484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
    Meschia JF; Merrill P; Soliman EZ; Howard VJ; Barrett KM; Zakai NA; Kleindorfer D; Safford M; Howard G
    Stroke; 2010 Apr; 41(4):581-7. PubMed ID: 20190000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.
    Casciano JP; Dotiwala ZJ; Martin BC; Kwong WJ
    J Manag Care Pharm; 2013 May; 19(4):302-16. PubMed ID: 23627576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter.
    Mentias A; Nakhla S; Desai MY; Wazni O; Menon V; Kapadia S; Vaughan Sarrazin M
    J Am Heart Assoc; 2021 Sep; 10(17):e021674. PubMed ID: 34431314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation.
    Zawawi NA; Abdul Halim Zaki I; Ming LC; Goh HP; Zulkifly HH
    Front Cardiovasc Med; 2021; 8():736143. PubMed ID: 34869639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.